<p>Gabelli Funds LLC 在最近向證券交易委員會提交的 13F 文件中表示，在第四季度將其在 ICU Medical, Inc. (NASDAQ:ICUI - 免費報告) 的股份減少了 13.2%。該機構投資者在此期間出售了 10,400 股後，持有 68,600 股該醫療器械供應商的股票。截至其最近的 SEC 文件，Gabelli Funds LLC 持有約 0.28% 的 ICU Medical，價值 9,787,000 美元。</p>
<p>其他大型投資者也買賣了該公司的股票。Covestor Ltd 在第三季度將其在 ICU Medical 的股份增加了 70.7%。Covestor Ltd 目前擁有 570 股該醫療器械供應商的股票，價值 68,000 美元，此前在上個季度又增購了 236 股。Strs Ohio 在第四季度將其在 ICU Medical 的股份增加了 60.0%。Strs Ohio 目前擁有 800 股該醫療器械供應商的股票，價值 114,000 美元，此前在此期間又購買了 300 股。Smartleaf Asset Management LLC 在第二季度將其在 ICU Medical 的股份增加了 11.6%。Smartleaf Asset Management LLC 目前擁有 969 股該醫療器械供應商的股票，價值 128,000 美元，此前在此期間又購買了 101 股。Headlands Technologies LLC 在第二季度購買了 ICU Medical 的新股份，價值 177,000 美元。最後，Allegheny Financial Group 在第四季度購買了 ICU Medical 的新股份，價值 214,000 美元。目前，96.10% 的股票由機構投資者持有。</p>
<h2>ICU Medical 股票上漲 0.5%</h2>
<p>ICUI 股票週三開盤價為 123.66 美元。該公司的速動比率為 1.17，流動比率為 2.34，債務與股本比率為 0.60。該公司的市值為 30.9 億美元，市盈率為 66.84，市盈增長比率為 1.77，貝塔值為 0.74。ICU Medical, Inc. 的 12 個月最低價為 107.00 美元，最高價為 160.29 美元。該股票的 50 天簡單移動平均線為 125.48 美元，200 天簡單移動平均線為 138.48 美元。</p>
<p>ICU Medical (NASDAQ:ICUI - 獲取免費報告) 最近一次發佈財報是在 5 月 7 日星期四。該醫療器械供應商報告該季度每股收益為 1.97 美元，超出分析師一致預期的 1.78 美元，超出幅度為 0.19 美元。該季度的營業收入為 5.2577 億美元，而分析師預期為 5.2065 億美元。ICU Medical 的股本回報率為 7.50%，淨利潤率為 2.15%。與去年同期相比，該公司的季度收入下降了 12.3%。在去年同期，該公司每股收益為 1.72 美元。ICU Medical 已將其 2026 財年的指導目標設定為每股收益 7.750-8.450 美元。平均而言，股票分析師預測 ICU Medical, Inc. 本財年將發佈每股收益 6.31 美元。</p>
<h2>分析師評級上調與下調</h2>
<p>ICUI 最近成為多份分析師報告的主題。Weiss Ratings 在 5 月 11 日星期一的研究報告中將 ICU Medical 的評級從 &#34;賣出 (d)&#34; 上調至 &#34;賣出 (d+)&#34;。Piper Sandler 在 4 月 17 日星期五的研究報告中將 ICU Medical 的目標價從 178.00 美元下調至 163.00 美元，並對該股票給予 &#34;增持&#34; 評級。KeyCorp 在 4 月 27 日星期一的研究報告中將 ICU Medical 的目標價從 180.00 美元下調至 164.00 美元，並對該股票給予 &#34;增持&#34; 評級。Jefferies Financial Group 在 5 月 7 日星期四的研究報告中將 ICU Medical 的評級上調至 &#34;強力買入&#34;。最後，Wall Street Zen 在 5 月 9 日星期六的研究報告中將 ICU Medical 的評級從 &#34;持有&#34; 上調至 &#34;買入&#34;。兩位研究分析師對該股票給予 &#34;強力買入&#34; 評級，兩位給予 &#34;買入&#34; 評級，一位對該公司給予 &#34;賣出&#34; 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;買入&#34;，共識目標價為 169.00 美元。</p>
<p><strong>獲取我們最新的 ICU Medical 股票分析</strong></p>
<h2>ICU Medical 的內部交易</h2>
<p>在其他 ICU Medical 新聞中，董事 David C. Greenberg 於 5 月 12 日星期二出售了 2,424 股 ICU Medical 股票。該股票的平均售價為 122.91 美元，總交易額為 297,933.84 美元。交易完成後，該董事持有 7,960 股公司股票，價值 978,363.60 美元。此次交易使其持股減少了 23.34%。該交易已在向證券交易委員會的文件中披露，相關信息可通過此鏈接獲取。此外，副總裁 Virginia Ruth Sanzone 於 5 月 14 日星期四出售了 2,447 股 ICU Medical 股票。該股票的平均售價為 124.08 美元，總價值為 303,623.76 美元。交易完成後，該副總裁直接持有 19,460 股公司股票，價值 2,414,596.80 美元。此次交易使其持股減少了 11.17%。有關此次出售的更多細節可在官方 SEC 披露中找到。2.10% 的股票由內部人士持有。</p>
<h2>ICU Medical 公司簡介</h2>
<p>(免費報告)</p>
<p>ICU Medical, Inc. 及其子公司開發、製造和銷售用於輸液治療、血管通路和生命監護應用的醫療設備。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢設備；ChemoClave 和 ChemoLock 封閉系統轉移設備，用於限制有害藥物或蒸汽濃度的逸出，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 非穿刺針用於門靜脈通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過 ICU Medical</li>
<li>HIVE 利用電力進行 AI 轉型</li>
<li>深入分析 NVIDIA 最新的投資組合動態</li>
<li>Brady Corp 進行大規模 AI 驅動的突破</li>
<li>為什麼 Home Depot 的拋售可能成為一個巨大的機會</li>
</ul>
<p><strong>想知道其他對 ICUI 感興趣的對沖基金持有哪些股票嗎？</strong> 請訪問 HoldingsChannel.com，獲取 ICU Medical, Inc.（NASDAQ:ICUI - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 ICU Medical 嗎？</h2>
<p>在考慮 ICU Medical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 ICU Medical 並不在名單上。</p>
<p>雖然 ICU Medical 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ICU醫療

<p>Gabelli Funds LLC 在 ICU Medical, Inc. 的持股減少了 13.2%，在第四季度出售了 10,400 股，目前持有 68,600 股，價值約 979 萬美元。其他投資者，包括 Covestor Ltd 和 Strs Ohio，增加了他們的持股。ICU Medical 的股票開盤價為 123.66 美元，市值為 30.9 億美元。該公司報告第一季度每股收益為 1.97 美元，超出預期，但收入同比下降了 12.3%。分析師的評級各異，普遍持 “買入” 評級，目標價為 169.00 美元</p>

<p>Gabelli Funds LLC cut its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 13.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,600 shares of the medical instruments supplier's stock after selling 10,400 shares during the period. Gabelli Funds LLC owned about 0.28% of ICU Medical worth $9,787,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Gabelli Funds LLC 在最近向證券交易委員會提交的 13F 文件中表示，在第四季度將其在 ICU Medical, Inc. (NASDAQ:ICUI - 免費報告) 的股份減少了 13.2%。該機構投資者在此期間出售了 10,400 股後，持有 68,600 股該醫療器械供應商的股票。截至其最近的 SEC 文件，Gabelli Funds LLC 持有約 0.28% 的 ICU Medical，價值 9,787,000 美元。</p>
</div><p>Other large investors have also bought and sold shares of the company. Covestor Ltd lifted its stake in ICU Medical by 70.7% during the 3rd quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier's stock valued at $68,000 after acquiring an additional 236 shares in the last quarter. Strs Ohio raised its stake in shares of ICU Medical by 60.0% during the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier's stock worth $114,000 after purchasing an additional 300 shares during the period. Smartleaf Asset Management LLC raised its stake in shares of ICU Medical by 11.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier's stock worth $128,000 after purchasing an additional 101 shares during the period. Headlands Technologies LLC bought a new stake in shares of ICU Medical during the 2nd quarter worth $177,000. Finally, Allegheny Financial Group bought a new stake in shares of ICU Medical during the 4th quarter worth $214,000. 96.10% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他大型投資者也買賣了該公司的股票。Covestor Ltd 在第三季度將其在 ICU Medical 的股份增加了 70.7%。Covestor Ltd 目前擁有 570 股該醫療器械供應商的股票，價值 68,000 美元，此前在上個季度又增購了 236 股。Strs Ohio 在第四季度將其在 ICU Medical 的股份增加了 60.0%。Strs Ohio 目前擁有 800 股該醫療器械供應商的股票，價值 114,000 美元，此前在此期間又購買了 300 股。Smartleaf Asset Management LLC 在第二季度將其在 ICU Medical 的股份增加了 11.6%。Smartleaf Asset Management LLC 目前擁有 969 股該醫療器械供應商的股票，價值 128,000 美元，此前在此期間又購買了 101 股。Headlands Technologies LLC 在第二季度購買了 ICU Medical 的新股份，價值 177,000 美元。最後，Allegheny Financial Group 在第四季度購買了 ICU Medical 的新股份，價值 214,000 美元。目前，96.10% 的股票由機構投資者持有。</p>
</div><h2>ICU Medical Stock Up 0.5%</h2>
<div class="lb-trans"><h2>ICU Medical 股票上漲 0.5%</h2>
</div><p>ICUI stock opened at $123.66 on Wednesday. The company has a quick ratio of 1.17, a current ratio of 2.34 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $3.09 billion, a PE ratio of 66.84, a PEG ratio of 1.77 and a beta of 0.74. ICU Medical, Inc. has a twelve month low of $107.00 and a twelve month high of $160.29. The stock has a 50-day simple moving average of $125.48 and a two-hundred day simple moving average of $138.48.</p>
<div class="lb-trans"><p>ICUI 股票週三開盤價為 123.66 美元。該公司的速動比率為 1.17，流動比率為 2.34，債務與股本比率為 0.60。該公司的市值為 30.9 億美元，市盈率為 66.84，市盈增長比率為 1.77，貝塔值為 0.74。ICU Medical, Inc. 的 12 個月最低價為 107.00 美元，最高價為 160.29 美元。該股票的 50 天簡單移動平均線為 125.48 美元，200 天簡單移動平均線為 138.48 美元。</p>
</div><p>ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, beating analysts' consensus estimates of $1.78 by $0.19. The business had revenue of $525.77 million during the quarter, compared to analyst estimates of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The company's quarterly revenue was down 12.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.72 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, equities analysts predict that ICU Medical, Inc. will post 6.31 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>ICU Medical (NASDAQ:ICUI - 獲取免費報告) 最近一次發佈財報是在 5 月 7 日星期四。該醫療器械供應商報告該季度每股收益為 1.97 美元，超出分析師一致預期的 1.78 美元，超出幅度為 0.19 美元。該季度的營業收入為 5.2577 億美元，而分析師預期為 5.2065 億美元。ICU Medical 的股本回報率為 7.50%，淨利潤率為 2.15%。與去年同期相比，該公司的季度收入下降了 12.3%。在去年同期，該公司每股收益為 1.72 美元。ICU Medical 已將其 2026 財年的指導目標設定為每股收益 7.750-8.450 美元。平均而言，股票分析師預測 ICU Medical, Inc. 本財年將發佈每股收益 6.31 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><p>ICUI has been the topic of a number of recent analyst reports. Weiss Ratings upgraded ICU Medical from a &#34;sell (d)&#34; rating to a &#34;sell (d+)&#34; rating in a research note on Monday, May 11th. Piper Sandler lowered their target price on ICU Medical from $178.00 to $163.00 and set an &#34;overweight&#34; rating on the stock in a research note on Friday, April 17th. KeyCorp lowered their target price on ICU Medical from $180.00 to $164.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, April 27th. Jefferies Financial Group upgraded ICU Medical to a &#34;strong-buy&#34; rating in a research note on Thursday, May 7th. Finally, Wall Street Zen upgraded ICU Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of &#34;Buy&#34; and a consensus target price of $169.00.</p>
<div class="lb-trans"><p>ICUI 最近成為多份分析師報告的主題。Weiss Ratings 在 5 月 11 日星期一的研究報告中將 ICU Medical 的評級從 &#34;賣出 (d)&#34; 上調至 &#34;賣出 (d+)&#34;。Piper Sandler 在 4 月 17 日星期五的研究報告中將 ICU Medical 的目標價從 178.00 美元下調至 163.00 美元，並對該股票給予 &#34;增持&#34; 評級。KeyCorp 在 4 月 27 日星期一的研究報告中將 ICU Medical 的目標價從 180.00 美元下調至 164.00 美元，並對該股票給予 &#34;增持&#34; 評級。Jefferies Financial Group 在 5 月 7 日星期四的研究報告中將 ICU Medical 的評級上調至 &#34;強力買入&#34;。最後，Wall Street Zen 在 5 月 9 日星期六的研究報告中將 ICU Medical 的評級從 &#34;持有&#34; 上調至 &#34;買入&#34;。兩位研究分析師對該股票給予 &#34;強力買入&#34; 評級，兩位給予 &#34;買入&#34; 評級，一位對該公司給予 &#34;賣出&#34; 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;買入&#34;，共識目標價為 169.00 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on ICU Medical</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 ICU Medical 股票分析</strong></p>
</div><h2>Insider Transactions at ICU Medical</h2>
<div class="lb-trans"><h2>ICU Medical 的內部交易</h2>
</div><p>In other ICU Medical news, Director David C. Greenberg sold 2,424 shares of ICU Medical stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total transaction of $297,933.84. Following the completion of the transaction, the director owned 7,960 shares of the company's stock, valued at $978,363.60. The trade was a 23.34% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. Also, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $124.08, for a total value of $303,623.76. Following the transaction, the vice president directly owned 19,460 shares of the company's stock, valued at $2,414,596.80. The trade was a 11.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 2.10% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他 ICU Medical 新聞中，董事 David C. Greenberg 於 5 月 12 日星期二出售了 2,424 股 ICU Medical 股票。該股票的平均售價為 122.91 美元，總交易額為 297,933.84 美元。交易完成後，該董事持有 7,960 股公司股票，價值 978,363.60 美元。此次交易使其持股減少了 23.34%。該交易已在向證券交易委員會的文件中披露，相關信息可通過此鏈接獲取。此外，副總裁 Virginia Ruth Sanzone 於 5 月 14 日星期四出售了 2,447 股 ICU Medical 股票。該股票的平均售價為 124.08 美元，總價值為 303,623.76 美元。交易完成後，該副總裁直接持有 19,460 股公司股票，價值 2,414,596.80 美元。此次交易使其持股減少了 11.17%。有關此次出售的更多細節可在官方 SEC 披露中找到。2.10% 的股票由內部人士持有。</p>
</div><h2>ICU Medical Profile</h2>
<div class="lb-trans"><h2>ICU Medical 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU Medical, Inc. 及其子公司開發、製造和銷售用於輸液治療、血管通路和生命監護應用的醫療設備。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢設備；ChemoClave 和 ChemoLock 封閉系統轉移設備，用於限制有害藥物或蒸汽濃度的逸出，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 非穿刺針用於門靜脈通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than ICU Medical</li>
<li>HIVE Weaponizes Power for an AI Pivot</li>
<li>A Deep Dive Into NVIDIA’s Latest Portfolio Moves</li>
<li>Brady Corp Wires Up a Massive AI-Powered Breakout</li>
<li>Why Home Depot’s Sell-Off Could Become a Huge Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 ICU Medical</li>
<li>HIVE 利用電力進行 AI 轉型</li>
<li>深入分析 NVIDIA 最新的投資組合動態</li>
<li>Brady Corp 進行大規模 AI 驅動的突破</li>
<li>為什麼 Home Depot 的拋售可能成為一個巨大的機會</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ICUI?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他對 ICUI 感興趣的對沖基金持有哪些股票嗎？</strong> 請訪問 HoldingsChannel.com，獲取 ICU Medical, Inc.（NASDAQ:ICUI - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ICUI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in ICU Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 ICU Medical 嗎？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 ICU Medical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 ICU Medical 並不在名單上。</p>
</div><p>While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 ICU Medical 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Gabelli Funds LLC Sells 10,400 Shares of ICU Medical, Inc. $ICUI

Market Beat

Piper Sandler Cos

Gabelli Funds LLC 出售了 10,400 股 ICU 醫療公司（ICU Medical, Inc.）的股票，股票代碼為$ICUI